A Complex Case of Retinoblastoma Solved by the Combined Approach of Humor/Plasma cfDNA-NGS and LR-WGS
Genes · 2025
DOI: 10.3390/genes16121399 ↗Kurz gefasst
Fallbericht in der Zeitschrift Genes, 2025. Verfasst von Simona Innamorato und 21 weiteren Autor:innen. Beteiligte Einrichtung: Medical Genetics, University of Siena, 53100 Siena, Italy. Hauptthemen laut MEDLINE: Retinoblastoma, Retinoblastoma Binding Proteins, Retinal Neoplasms, Cell-Free Nucleic Acids. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Liquid Eye Project - Development of new strategies for saving eye in retinoblastoma relapse, PROGETTO PNRR - NEXT GENERATION EU: MISSIONE 4 COMPONENTE 2 (M4C2) - INVESTIMENTO 1.4 - ACRONIMO MNRA - SPOKE 1 NATIONAL CENTER FOR GENE THERAPY AND DRUGS BASE…, PROGETTO PNC-E.3 INNOVA Ecosistema innovativo della Salute - Missione 6 - Componente 2 - Innovazione, ricerca e digitalizzazione del servizio sanitario naziona….
Abstract (Originalsprache)
Background
Complex cases of retinoblastoma (RB) often require integrative molecular approaches to define tumor etiology and guide clinical management.
Purpose
Our aim was to evaluate the usefulness of combining aqueous humor (AH)/plasma cell-free DNA next-generation sequencing (cfDNA-NGS) and long-read–whole-genome sequencing (LR-WGS) to resolve diagnostically challenging RB cases. Case Description: We report the case of a 3-year-old Caucasian girl, conceived by heterologous assisted reproductive technology (ART), presenting with unilateral, widely infiltrative RB in the right eye. She exhibited limited verbal communication, a glabellar angioma extending to the nasal bridge and philtrum, and mild hypertelorism. Standard blood testing revealed no pathogenic SNVs, CNVs, or methylation abnormalities in the RB1 gene. Targeted cfDNA analysis using the Illumina TruSight Oncology 500 (TSO500) panel on AH and plasma identified a somatic RB1 splice-site variant (c.1498+2T>C) with a variant allele frequency (VAF) of 98.5%, consistent with biallelic inactivation. Additional gains (fold change > 1.5) were found in AH and confirmed in plasma, suggesting a germline 13q duplication. Third-generation LR-WGS, performed with Oxford Nanopore Technology (ONT), on blood confirmed a 24.6 Mb duplication on chromosome 13, compatible with the rare 13q duplication syndrome characterized by psychomotor delay, craniofacial dysmorphism, and hemangiomas. AH-cfDNA revealed additional somatic copy-number alterations, including amplifications (i.e., MDM4 and ALK) and deletions (i.e., BRCA2), indicating progressive clonal tumor evolution.
Conclusions
This experience tells us that a combined approach with TSO500 Illumina NGS on cfDNA, along with LR-WGS, is able to help solve complex cases and define the appropriate treatment and surveillance strategy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Medical Genetics, University of Siena, 53100 Siena, Italy.
- Department of Medical Biotechnologies, Med Biotech Hub and Competence Center, University of Siena, 53100 Siena, Italy.
- Genetica Medica, Azienda Ospedaliero-Universitaria Senese, 53100 Siena, Italy.
- Unit of Pathological Anatomy, Azienda Ospedaliera Universitaria Senese, 53100 Siena, Italy.
- Unit of Pediatrics, Department of Maternal, Newborn and Child Health, Azienda Ospedaliera Universitaria Senese, 53100 Siena, Italy.
- Unit of NeuroImaging and NeuroIntervention, Azienda Ospedaliera Universitaria Senese, 53100 Siena, Italy.
ORCID-Profile: Simona Innamorato, Omaima Belakhdar, Chiara Fallerini, Elena Pasquinelli, Stefano Lazzi, Anna Maria Pinto, Alessandra Renieri
Förderung
- Liquid Eye Project - Development of new strategies for saving eye in retinoblastoma relapse
- PROGETTO PNRR - NEXT GENERATION EU: MISSIONE 4 COMPONENTE 2 (M4C2) - INVESTIMENTO 1.4 - ACRONIMO MNRA - SPOKE 1 NATIONAL CENTER FOR GENE THERAPY AND DRUGS BASE…
- PROGETTO PNC-E.3 INNOVA Ecosistema innovativo della Salute - Missione 6 - Componente 2 - Innovazione, ricerca e digitalizzazione del servizio sanitario naziona…
- PROGETTO GENERA FSC 2014-2020 - Genoma mEdiciNa pERsonalizzatA , - POS-Ministero della Salute T3-AN-04
- PROGETTO UE SCREEN4CARE - NEWBORN GENETIC SCREENING FOR PREVENTION AND TREATMENT OF RARE GENETIC DISEASES N. PROPOSAL NUMBER 101034427-1
- PROGETTO EU H2020-SC1-FA-DTS-2018-2020, International consortium for integrative genomics prediction - Grant Agreement No. 101016775
- PNRR THE - TUSCANY HEALTH ECOSYSTEM HA PARLATO N. 7 MEDICINA TRASLAZIONALE PER MALATTIE RARE, ONCOLOGICHE E INFETTIVE
- ERDERA Diagnostic Research Workstream
Zitieren
APA
Innamorato, S., Basso, S. L., Belakhdar, O., Bruttini, M., Fallerini, C., Huseynli, H., Caccialupi, G., Pasquinelli, E., Adduci, M., Signori, G., Arcuri, F., Malagnino, V., Siciliano, M. C., Lazzi, S., Pesaresi, S., Galimberti, D., Galluzzi, P., De Francesco, S., Hadijstillanou, T., …, & Ariani, F. (2025). A Complex Case of Retinoblastoma Solved by the Combined Approach of Humor/Plasma cfDNA-NGS and LR-WGS. Genes. https://doi.org/10.3390/genes16121399
Vancouver
Innamorato S, Basso SL, Belakhdar O, Bruttini M, Fallerini C, Huseynli H, et al. A Complex Case of Retinoblastoma Solved by the Combined Approach of Humor/Plasma cfDNA-NGS and LR-WGS. Genes. 2025. doi:10.3390/genes16121399
BibTeX
@article{Innamorato2025,
author = {Innamorato, Simona and Basso, Simona L and Belakhdar, Omaima and Bruttini, Mirella and Fallerini, Chiara and Huseynli, Heyran and Caccialupi, Giulia and Pasquinelli, Elena and Adduci, Mariarosaria and Signori, Giorgio and Arcuri, Felice and Malagnino, Valeria and Siciliano, Maria Chiara and Lazzi, Stefano and Pesaresi, Simone and Galimberti, Daniela and Galluzzi, Paolo and De Francesco, Sonia and Hadijstillanou, Theodora and Pinto, Anna Maria and Renieri, Alessandra and Ariani, Francesca},
title = {A Complex Case of Retinoblastoma Solved by the Combined Approach of Humor/Plasma cfDNA-NGS and LR-WGS},
journal = {Genes},
year = {2025},
doi = {10.3390/genes16121399}
}
EUVIMED